Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 14/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | RARA | P10276 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | RARG | P13631 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19754717 | 1.00 | PDK2 (0.39) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL19754727 | 1.00 | PDK2 (0.39) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL19754688 | 1.00 | PDK2 (0.39) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL19754711 | 1.00 | PDK2 (0.39) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL19754703 | 1.00 | PDK2 (0.39) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL19754689 | 1.00 | PDK2 (0.39) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL19754705 | 1.00 | PDK2 (0.39) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL24169354 | 0.99 | PDK2 (0.37) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL24169328 | 0.99 | PDK2 (0.37) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL24169663 | 0.99 | PDK2 (0.37) | PDK2MEN1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172061-A1 | COMPOSITION FOR OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172061-A1 | COMPOSITION FOR OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-10672990-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2020-06-02 | — | — | US | disclosed |
| US-20170373255-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170373255-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OXER1, OCIAD1, OR10J3 | PDK2 2662/4885MEN1 2434/4885ALDH1A1 60/4885 |
| US-10672990-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device | OXER1, OCIAD1, OR10J3 | PDK2 2662/4885MEN1 2434/4885ALDH1A1 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.